A pragmatic study of mid‐mixture insulin and basal insulin treatment in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic medications: A lesson from real‐world experience-Reference-Cited by-同舟云学术

A pragmatic study of mid‐mixture insulin and basal insulin treatment in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic medications: A lesson from real‐world experience

Published:2020-05-11 Issue:8 Volume:22 Page:1436-1442
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Zhang Xiaomei¹,Ma Yujin²,Chen Hong³,Lou Ying³,Ji Linong⁴^ORCID,Chen Lulu⁵^ORCID

Affiliation:

1. Department of EndocrinologyPeking University International Hospital Beijing China

2. Department of EndocrinologyFirst Hospital, affiliate with Henan University of Science and Technology Luoyang China

3. Lilly Suzhou Pharmaceutical Co. Ltd Shanghai China

4. Department of EndocrinologyPeking University People’s Hospital Beijing China

5. Department of Endocrinology, Hubei Provincial, Clinical Research Center for Diabetes and Metabolic DisordersTongji Medical College, Union Hospital, Huazhong University of Science and Technology Wuhan China

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14052

Reference34 articles.

1. World Health Organization. Diabetes.https://www.who.int/news-room/fact-sheets/detail/diabetes. Accessed July 16 2019.

2. KaiserAB ZhangN PluijmWVD. Global prevalence of type 2 diabetes over the next ten years (2018–2028); 2018 Poster Diabetes; 67.

3. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013

4. International Diabetes Federation IDF Diabetes Atlas 9th edition2019.https://www.diabetesatlas.org/en/sections/demographic-and-geographic-outline.html. Accessed November 20 2019.

5. Early therapy for type 2 diabetes in China

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of biosynthetic human insulin and its analogues for diabetes management;Advances in Protein Chemistry and Structural Biology;2024

2. Efficacy and safety of a basal insulin + 2‐3 oral antihyperglycaemic drugs regimen versus a twice‐daily premixed insulin + metformin regimen after short‐term intensive insulin therapy in individuals with type 2 diabetes: The multicentre, open‐label, randomized controlled BEYOND‐V trial;Diabetes, Obesity and Metabolism;2022-06-28

3. Efficacy and safety benefits of iGlarLixi versus insulin glargine 100 U/ mL or lixisenatide in Asian Pacific people with suboptimally controlled type 2 diabetes on oral agents: The LixiLan‐O‐AP randomized controlled trial;Diabetes, Obesity and Metabolism;2022-05-12

4. Effects of basal and premixed insulin on glycemic control in type 2 diabetes patients based on multicenter prospective real‐world data;Journal of Diabetes;2022-01-13

5. A Pragmatic Study of Basal and Mid-Mixture Insulins as Starter Insulins in Chinese Patients With Type 2 Diabetes: Observations From Long-Term, Real-World Experience;Diabetes Therapy;2021-02-22